Updates in Cardiac Amyloidosis: A Review

Updates in Cardiac Amyloidosis: A Review

Bibliographic Details
Main Authors:	Banypersad, Sanjay M., Moon, James C., Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh D.
Format:	Online
Language:	English
Published:	Blackwell Publishing Ltd 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487372/

Similar Items

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
by: Dungu, Jason, et al.
Published: (2012)

T1 mapping and survival in systemic light-chain amyloidosis
by: Banypersad, Sanjay M., et al.
Published: (2015)

DPD Scintigraphy for diagnosis of amyloidosis in 1191 patients– a single centre experience
by: Hutt, David, et al.
Published: (2015)

LGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
by: Fontana, Marianna, et al.
Published: (2015)

Systemic Amyloidosis in England: an epidemiological study
by: Pinney, Jennifer H, et al.
Published: (2013)

Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study
by: Banypersad, Sanjay M, et al.
Published: (2014)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
by: Fontana, Marianna, et al.
Published: (2014)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
by: Fontana, Marianna, et al.
Published: (2015)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
by: Karamitsos, Theodoros, et al.
Published: (2012)

Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
by: Banypersad, Sanjay M, et al.
Published: (2012)

Diagnostic value of fat aspirates for amyloidosis in 950 patients
by: Gilbertson, JA, et al.
Published: (2015)

OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis
by: Lane, T, et al.
Published: (2013)

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
by: Pinney, Jennifer H., et al.
Published: (2013)

Spotting senile systemic amyloidosis: why we miss it
by: Fontana, Marianna, et al.
Published: (2015)

Quality of life in ATTR amyloidosis
by: Lane, Thirusha, et al.
Published: (2015)

Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis
by: Banypersad, Sanjay M, et al.
Published: (2013)

Analysis of disease progression in patients with transthyretin cardiac amyloidosis
by: Gilmore, Julian D, et al.
Published: (2015)

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study
by: Quarta, Candida C, et al.
Published: (2015)

Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis
by: Treibel, Thomas A., et al.
Published: (2015)

Five novel TTR variants: associated phenotypes and structural consequences
by: Rowczenio, Dorota, et al.
Published: (2015)

Empirical use of anakinra in AA amyloidosis of uncertain aetiology
by: Lane, T, et al.
Published: (2015)

NUCLEAR IMAGING IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS
by: V. B. Sergienko, et al.
Published: (2018-01-01)

Equilibrium contrast CMR for the detection of amyloidosis in mice
by: Campbell, Adrienne E, et al.
Published: (2011)

Cardiac Amyloidosis Determines the Prognosis of Systemic Amyloidosis; Roles and Responsibilities of Cardiologist
by: Lee, Ga Yeon, et al.
Published: (2013)

Evolving landscape in the management of transthyretin amyloidosis
by: Hawkins, Philip N., et al.
Published: (2015)

Incidence, Diagnosis and Prognosis of Cardiac Amyloidosis
by: Lee, Min-Ho, et al.
Published: (2013)

Cardiac Amyloidosis Diagnosed by Endomyocardial Biopsy
by: Kim, Myung A, et al.
Published: (1988)

Light chain (AL) amyloidosis: update on diagnosis and management
by: Rosenzweig, Michael, et al.
Published: (2011)

Hepatic amyloidosis
by: Shin, Yong Moon
Published: (2011)

Subtype‐Specific Interactions and Prognosis in Cardiac Amyloidosis
by: Sperry, Brett W., et al.
Published: (2016)

Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis
by: Gillmore, Julian D, et al.
Published: (2015)

Ischemic Hepatitis as the Presenting Manifestation of Cardiac Amyloidosis
by: Petz, Chelsey A., et al.
Published: (2014)

Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison
by: Ebrille, Elisa, et al.
Published: (2013)

Amyloidosis
by: Reddy, D. J.
Published: (1951)

AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology
by: Fontana , Marianna, et al.
Published: (2014)

Unique type of isolated cardiac valvular amyloidosis
by: Iqbal, Shehzad, et al.
Published: (2006)

Isolated Tricuspid Regurgitation: Initial Manifestation of Cardiac Amyloidosis
by: Yoon, Dong Woog, et al.
Published: (2015)

A Concise Review of Amyloidosis in Animals
by: Woldemeskel, Moges
Published: (2012)

Amyloidosis
Published: (1951)

Primary Systemic Amyloidosis
by: Wahi, P. N., et al.
Published: (1950)